There have been significant advances, especially in understanding the role of carrier properties on the aerosol performance of the API. Dry powder inhalers (DPIs) have advanced significantly over the ...

Asthma patients using dry powder inhalers are more likely to adherence to inhaled corticosteroid therapy than those using metered-dose inhalers, a new study has shown. Researchers studied 270 adults ...

A single-use DPI from Perlen Packaging, which offers lower-cost production and a more affordable device for emerging markets, won a 2017 CPhI Pharma Award. Inhalation drug products can be delivered ...

Inhaled medications are the mainstay of pharmacological treatment for people with chronic obstructive pulmonary disease and asthma. This second article in a two-part series describes the procedure for ...

Background and Goal: This study examined whether patients with non-reversible chronic airway disease using a transparent capsule in single-dose dry powder inhalers affects the amount of medication ...

In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder inhalers (DPIs) for respiratory conditions that are more eco-friendly than ...

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 billion by 2034. The Industry is expected to surge at a CAGR of 3.70% from ...

Climbing to New Heights: The Global Dry Powder Inhaler Industry Anticipates Impressive 4.6% CAGR Growth from 2021 to 2031, Envisioning a Market Valued at Approximately US$ 18.9 Billion in 2021. Future ...

Switching to “green” inhalers could cut greenhouse gas emissions and reduce drug costs, according to a study by the University of Cambridge. Researchers looked at prescription data from England in ...

The Dry Powder Inhaler Market is poised for significant growth, with a market value of USD 20.83 billion in 2024, projected to climb to USD 29.95 billion by 2034, representing a steady CAGR of 3.70% ...